Gastroenteropancreatic System and Its Tumors Part II An Issue of Endocrinology and Metabolism Clinics 1st Edition at Meripustak

Gastroenteropancreatic System and Its Tumors Part II An Issue of Endocrinology and Metabolism Clinics 1st Edition

Books from same Author: Vinik, Aaron

Books from same Publisher: Elseiver

Related Category: Author List / Publisher List


  • Retail Price: ₹ 8771/- [ 5.00% off ]

    Seller Price: ₹ 8332

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)Vinik, Aaron
    PublisherElseiver
    Edition1st Edition
    ISBN9781455704408
    Pages288
    LanguageEnglish
    Publish YearMarch 2011

    Description

    Elseiver Gastroenteropancreatic System and Its Tumors Part II An Issue of Endocrinology and Metabolism Clinics 1st Edition by Vinik, Aaron

    This two-part issue of Endocrinology and Metabolism Clinics of North America provides the endocrinologist with comprehensive essential updates about tumors of the gastroenteropancreatic system. Topics covered include the history and development of the gastroenteropancreatic endocrine axis; the changing face and epidemiology of neuroendocrine tumors (NETs); chromogranins current state of the art, pathology of gastroenteropancreatic (GEP) disorders; new and emerging syndromes related to gastrointestinal (GI) hormones; an update on incretins; prospects for ghrelin in the clinic, obesity/appetite and hedonism; GI motility disorders; gastric bypass and GI hormones; pancreatic exocrine function and GI hormones; harnessing the pancreatic stem cell; how to diagnose NETs before there are METs; NETs in kids: combining the SEER data for children and adults with site differences; novel biomarkers for NETs; standard imaging techniques for NETs; novel peptide imaging: glucagon receptor; signaling mechanism in NETs as targets for therapy; update on clinical trials; nutrition and the GEP; peptide radiotherapy; in vitro analysis of NETs: the role of angiogenesis; modern lab evaluation of peptide and amines: a continuing role for radioimmunoassay?; surgery/surgical management of NETs; and evaluation and quality of life in NETs patients._x000D_